Neptune Technologies

• Reasons to Buy This Pharmaceutical Company

  By Mohsin Saeed - February 11, 2013 | Tickers: AMRN, GSK, NEPT

  The small pharmaceutical companies have a number of weaknesses when compared to big pharmaceuticals. While they usually have competent management that can effectively oversee the development of a drug candidate, it is extremely rare that they also possess the resources to effectively market their own product. This is the very reason small pharmaceuticals are such attractive acquisition plays. If a company has managed to develop an interesting candidate it is more »